Search Results - "Habashy, Hany Onsy"

Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen by Habashy, Hany Onsy, Powe, Desmond G, Staka, Cindy M, Rakha, Emad A, Ball, Graham, Green, Andrew R, Aleskandarany, Mohammed, Paish, E. Claire, Douglas Macmillan, R, Nicholson, Robert I, Ellis, Ian O, Gee, Julia M. W

“…Transferrin receptor (CD71) is involved in the cellular uptake of iron and is expressed on cells with high proliferation. It may be implicated in promoting the…”
Get full text

Forkhead-box A1 (FOXA1) expression in breast cancer and its prognostic significance by Habashy, Hany Onsy, Powe, Desmond G, Rakha, Emad A, Ball, Graham, Paish, Claire, Gee, Julia, Nicholson, Robert I, Ellis, Ian O

“…Abstract The forkhead-box A1 (FOXA1) controls downstream transcription of oestrogen receptor (ER)-regulated genes. In this study, the biological and prognostic…”
Get full text

Expression levels of βcatenin and galectin-3 in meningioma and their effect on brain invasion and recurrence： a tissue microarray study by Ahmed, Rehab Allah, Shebl, Abdelhadi M, Habashy, Hany Onsy

“…Objective： Meningiomas are neoplasms that arise from the meninges of the central nervous system （CNS）. They constitute about 25.6% of CNS tumors diagnosed in…”
Get full text

RRM2 expression in different molecular subtypes of breast cancer and its prognostic significance by Abdel-Rahman, Manar Ahmed, Mahfouz, Mena, Habashy, Hany Onsy

“…Breast cancer is one of the most common types of cancer. Ribonucleotide reductase (RNR) is a heterodimeric tetramer consisting of two…”
Get full text

The oestrogen receptor coactivator CARM1 has an oncogenic effect and is associated with poor prognosis in breast cancer by Habashy, Hany Onsy, Rakha, Emad A., Ellis, Ian O., Powe, Desmond G.

“…The coactivator-associated arginine methyltransferase-1 (CARM1) is implicated in regulation of oestrogen receptor (ER) α-mediated gene pathways in response to…”
Get full text

prognostic significance of PELP1 expression in invasive breast cancer with emphasis on the ER-positive luminal-like subtype by Habashy, Hany Onsy, Powe, Desmond G, Rakha, Emad A, Ball, Graham, Macmillan, R. Douglas, Green, Andrew R, Ellis, Ian O

“…The transcription functions of oestrogen receptors (ER) are influenced by several coregulators such as PELP1 (proline, glutamate and leucine rich protein 1)…”
Get full text

FOXO3a nuclear localisation is associated with good prognosis in luminal-like breast cancer by Habashy, Hany Onsy, Rakha, Emad A., Aleskandarany, Mohammed, Ahmed, Mohamed AH, Green, Andrew R., Ellis, Ian O., Powe, Desmond G.

“…Oestrogen receptor (ER)-positive breast cancer (BC) constitutes a heterogeneous group of tumours with regard to outcome and response to therapy. Accurate…”
Get full text

RERG (Ras-like, oestrogen-regulated, growth-inhibitor) expression in breast cancer: a marker of ER-positive luminal-like subtype by Habashy, Hany Onsy, Powe, Desmond G., Glaab, Enrico, Ball, Graham, Spiteri, Inmaculada, Krasnogor, Natalio, Garibaldi, Jonathan M., Rakha, Emad A., Green, Andrew R., Caldas, C., Ellis, Ian O.

“…Global gene expression profiling studies have classified breast cancer into a number of distinct biological and molecular classes with clinical relevance. The…”
Get full text

Nuclear Factor-κB Clinical Significance in Breast Cancer: An Immunohistochemical Study by Al-Mutairi, Mashael Saqer, Habashy, Hany Onsy

“…Objectives: Nuclear factor κB (NF-κB) is a superfamily of transcription factors that plays a key role in cancer genesis and progression. The present study…”
Get full text

Expression levels of β-catenin and galectin-3 in meningioma and their effect on brain invasion and recurrence: a tissue microarray study by Rehab Allah Ahmed Abdelhadi M Shebl Hany Onsy Habashy

“…Objective: Meningiomas are neoplasms that arise from the meninges of the central nervous system (CNS). They constitute about 25.6% of CNS tumors diagnosed in…”
Get full text

Investigating AP-2 and YY1 protein expression as a cause of high HER2 gene transcription in breast cancers with discordant HER2 gene amplification by Powe, Desmond G, Akhtar, Gulfareen, Habashy, Hany Onsy, Abdel-Fatah, Tarek, Rakha, Emad A, Green, Andrew R, Ellis, Ian O

“…Candidacy for anti-HER2 adjuvant therapy in breast cancer is assessed using tumour HER2 status but recently it has been proposed that the transcription factors…”
Get full text

The biological heterogeneity of oestrogen receptor positive breast cancer and its phenotypic characterisation by Habashy, Hany Onsy Fouad Ibrahim

“…Although global gene microarray studies have demonstrated the molecular heterogeneity of breast cancer (BC) and provided potential for clinical applications,…”
Get full text